Parametric Portfolio Associates’s Trinity Biotech TRIB Stock Holding History

Parametric Portfolio Associates’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-46,029	Closed	-$1.29M	–	3943
2017 Q3	$1.29M	Buy	46,029 +307	+0.7%	+$8.56K	﹤0.01%	2885
2017 Q2	$1.37M	Buy	45,722 +44	+0.1%	+$1.25K	﹤0.01%	2796
2017 Q1	$1.36M	Buy	45,678 +3	+0%	+$94	﹤0.01%	2701
2016 Q4	$1.58M	Sell	45,675 -5,397	-11%	-$186K	﹤0.01%	2542
2016 Q3	$3.38M	Hold	51,072	–	–	0.01%	1931
2016 Q2	$2.9M	Buy	51,072 +3,132	+7%	+$177K	﹤0.01%	2028
2016 Q1	$2.79M	Buy	+47,940	New	+$2.54M	﹤0.01%	2115

Other funds holding TRIB

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Russell Investments Group

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Boston Partners

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return